Compare BIOA & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIOA | SMID |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 206.7M |
| IPO Year | 2024 | 1995 |
| Metric | BIOA | SMID |
|---|---|---|
| Price | $12.56 | $34.39 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.33 | N/A |
| AVG Volume (30 Days) | ★ 410.3K | 8.9K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | N/A | ★ 2.22 |
| Revenue | $5,917,000.00 | ★ $88,866,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | ★ 16.37 |
| 52 Week Low | $2.88 | $25.13 |
| 52 Week High | $13.10 | $50.37 |
| Indicator | BIOA | SMID |
|---|---|---|
| Relative Strength Index (RSI) | 77.86 | 47.16 |
| Support Level | $12.00 | $31.52 |
| Resistance Level | $13.10 | $36.00 |
| Average True Range (ATR) | 0.72 | 1.73 |
| MACD | 0.26 | 0.17 |
| Stochastic Oscillator | 88.25 | 52.06 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.